Biotech · Private company
Sobi, Inc.
Track this companyFree. Adds Sobi, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials1611 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- AvatrombopagPhase 3 · Chemotherapy-induced ThrombocytopeniaClinicalTrials.gov · fetched Nov 12, 2026
- AvatrombopagPhase 3 · Immune ThrombocytopeniaClinicalTrials.gov · fetched Nov 12, 2026
- Avatrombopag 60 mgPhase 3 · ThrombocytopeniaClinicalTrials.gov · fetched Nov 12, 2026
- AvatrombopagThrombocytopeniaClinicalTrials.gov · fetched Nov 12, 2026
- Avatrombopag Oral TabletImmune ThrombocytopeniaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials16
- Time-limited Treatment With Avatrombopag Pre- and Post-CAR T-cell Therapy to Prevent Post-CAR T-cell CytopeniasPHASE2 · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07895017 · fetched Nov 12, 2026
- Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With CytopeniasPHASE2 · RECRUITING · started Oct 23, 2026ClinicalTrials.gov NCT07447817 · fetched Nov 12, 2026
- Severe Hepatitis Intervention With Emapalumab for Liver DiseasePHASE2 · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07744919 · fetched Nov 12, 2026
- Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) RecipientsEARLY_PHASE1 · RECRUITING · started Jan 7, 2026ClinicalTrials.gov NCT07244419 · fetched Nov 12, 2026
- Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic LeukemiaPHASE2 · RECRUITING · started Jan 1, 2026ClinicalTrials.gov NCT07033598 · fetched Nov 12, 2026
- A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström MacroglobulinemiaPHASE2 · RECRUITING · started Nov 21, 2025ClinicalTrials.gov NCT06986174 · fetched Nov 12, 2026
- MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)RECRUITING · started Sep 26, 2025ClinicalTrials.gov NCT07362225 · fetched Nov 12, 2026
- Pacritinib in CMMLPHASE1_PHASE2 · RECRUITING · started Sep 18, 2024ClinicalTrials.gov NCT06159491 · fetched Nov 12, 2026
- A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged CytopeniaPHASE2 · RECRUITING · started Jul 5, 2024ClinicalTrials.gov NCT06285825 · fetched Nov 12, 2026
- A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory ConditionPHASE2 · RECRUITING · started Mar 15, 2023ClinicalTrials.gov NCT05787574 · fetched Nov 12, 2026
- INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)RECRUITING · started Dec 31, 2021ClinicalTrials.gov NCT05277272 · fetched Nov 12, 2026
- Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or RomiplostimPHASE4 · COMPLETED · started Mar 15, 2021ClinicalTrials.gov NCT04638829 · fetched Nov 12, 2026
- Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 MonthsPHASE3 · COMPLETED · started Mar 5, 2021ClinicalTrials.gov NCT04516967 · fetched Nov 12, 2026
- Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological CancersPHASE3 · COMPLETED · started Oct 12, 2018ClinicalTrials.gov NCT03471078 · fetched Nov 12, 2026
- Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a ProcedureTERMINATED · started Jul 2, 2018ClinicalTrials.gov NCT03554759 · fetched Nov 12, 2026
- Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical ProcedurePHASE3 · TERMINATED · started Mar 26, 2018ClinicalTrials.gov NCT03326843 · fetched Nov 12, 2026